Pulmatrix, Inc. Stockholders Approve Merger-Related Proposals and Reverse Stock Split

Pulmatrix stockholders approved issuing common shares representing more than 20% of shares outstanding immediately before the issuance, in connection with the proposed merger with Eos SENOLYTIX. The meeting was held October 26, 2026; the supplied text does not establish that the merger itself has closed.